A breakthrough phyto-medicine for Osteoarthritis (OA) further proved its efficacy with the first local clinical study that shows sustained pain-relief to individuals suffering from the joint disease that affects 11 million Filipinos.
Arthrite, the first traditional herbal medicine approved by the Philippine Food and Drug Administration (FDA) for joint pain, consists of 14 herbal components that work synergistically to reduce pain caused by osteoarthritis. Apart from pain relief, Arthrite contains several active herbal ingredients which are responsible for reducing joint inflammation, pain management and improving joint mobility.
“Osteoarthritis has been affecting millions of lives, limiting one’s ability to perform daily tasks, reducing the quality of life and even contributing to the development of depression among elderly patients. But we need not suffer all throughout our lives because there is an effective and safe medication that can provide relief from joint pain, Arthrite is the answer to osteoarthritis!” said Dr. Eduardo Rommel Poblete, Assistant Director and Fellowship Training Officer, Geriatric Center, St. Luke’s Medical Center-Quezon City.
To further prove the efficacy and safety of Arthrite in providing symptomatic relief to patients with mild to moderate osteoarthritis, a local clinical study was conducted by Dr. Poblete. The clinical trial tested 60 patients, with ages ranging from 45 years old and up, who were clinically diagnosed with mild-moderate osteoarthritis. For the duration of 8 weeks, patients were prescribed to take 2 Arthrite capsules after breakfast and 2 capsules after dinner, for a total of 120 capsules for a period of 2 months. Patients were also prescribed to take 1 tablet in the morning of a non-steroidal anti-inflammatory drug (NSAID) called Meloxicam as a rescue medication.
As a result, the physician’s global evaluation showed that 83% of the patients experienced moderately effective pain relief and 17% had very effective pain relief on first month of observation. During the second month of physician’s global evaluation, 45% experienced moderate effectiveness; 30% had very effective pain relief; and 25% were symptom-free. Patient’s global assessment in the first month shows majority (75%) had experienced moderate effectiveness, followed by very high effectiveness (23%) and symptom-free (3.2%).
No side effects were reported during the clinical trials and the physicians global evaluation revealed a positive result from moderately effective to symptoms free after 2 months of treatment. Meanwhile, Patient’s global assessment shows beneficial effect specifically to pain. Majority of the patients were symptom-free after 2 months of treatment.
Due to the effectiveness of Arthrite, it has been recommended to be part of the treatment regimen of patients with mild to moderate osteoarthritis.
For more information about Arthrite, please visit www.multicare.com.ph.
Comments
Post a Comment